Who owns Corcept Therapeutics Incorporated?

Key details on Corcept Therapeutics Incorporated (Ticker: CORT)

Who owns Corcept Therapeutics Incorporated?

Is CORT a good stock to own? Find out who bought Corcept Therapeutics Incorporated, who sold Corcept Therapeutics Incorporated (CORT) stock, and who holds a large position in Corcept Therapeutics Incorporated.

Fund Name Number of Shares Share Valuation As Of
Federated Investors 14.18M $53.30M Sept. 30, 2015
Vanguard 7.14M $26.84M Sept. 30, 2015
TimesSquare Capital Management 4.10M $11.45M Sept. 30, 2012
Credit Suisse AG 2.73M $7.61M Sept. 30, 2012
BlackRock Institutional Trust Company, N.A. 2.47M $9.28M Sept. 30, 2015
Jennison Associates 2.15M $9.38M March 31, 2014
MORGAN STANLEY 2.15M $8.09M Sept. 30, 2015
Investor AB 1.83M $6.89M Sept. 30, 2015
BlackRock Fund Advisors 1.62M $6.08M Sept. 30, 2015
First Eagle Investment Management 991978 $3.19M Dec. 31, 2013
STATE STREET CORPORATION 851519 $3.20M Sept. 30, 2015
TCW 718786 $1.03M Dec. 31, 2012

Who sold Corcept Therapeutics Incorporated?

Fund Name Date Sold Number of Shares Sold Share Valuation
Adage Capital Partners GP March 31, 2013 1.01M $2.03M
Franklin Resources March 31, 2011 988800 $4.20M
Maverick Capital March 31, 2008 1.38M $4.43M